STOCK TITAN

[8-K] BrightSpring Health Services, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

BrightSpring Health Services (BTSG) disclosed an underwritten secondary offering of 15,000,000 shares of common stock by selling stockholders, including KKR Phoenix Aggregator L.P., under an automatic shelf on Form S-3ASR. The closing of the offering and related share repurchase occurred on October 22, 2025.

The Company did not receive proceeds from the offering, other than cash received from Management Selling Stockholders’ stock option exercises in connection with the transaction. BrightSpring repurchased 1,500,000 shares from the underwriter as part of the offering, and the underwriter did not receive underwriting fees on the repurchased shares. The underwriting agreement includes customary representations, conditions, and indemnification provisions.

BrightSpring Health Services (BTSG) ha annunciato un'offerta secondaria garantita di 15.000.000 azioni ordinarie da parte degli azionisti venditori, tra cui KKR Phoenix Aggregator L.P., nell'ambito di un deposito automatico conforme al Form S-3ASR. Il completamento dell'offerta e il relativo riacquisto di azioni hanno avuto luogo il 22 ottobre 2025.

L'azienda non ha incassato proventi dall'offerta, se non i contanti ricevuti dall'esercizio delle opzioni azionarie da parte degli Management Selling Stockholders in relazione all'operazione. BrightSpring ha riacquistato 1.500.000 azioni dall'intermediario come parte dell'offerta, e l'intermediario non ha ricevuto commissioni di sottoscrizione sulle azioni riacquistate. L'accordo di sottoscrizione comprende dichiarazioni, condizioni e disposizioni di indennizzo di prassi.

BrightSpring Health Services (BTSG) divulgó una oferta secundaria garantizada de 15,000,000 acciones comunes por parte de accionistas vendedores, entre ellos KKR Phoenix Aggregator L.P., dentro de un aumento automático según el Formulario S-3ASR. El cierre de la oferta y la recompra de acciones relacionada se realizó el 22 de octubre de 2025.

La Compañía no recibió ingresos de la oferta, excepto el efectivo recibido por los ejercicios de opciones de acciones de los accionistas de administración vendedores en relación con la transacción. BrightSpring recompró 1,500,000 acciones de la aseguradora como parte de la oferta, y la aseguradora no recibió comisiones de suscripción sobre las acciones recompradas. El acuerdo de suscripción incluye representaciones, condiciones y disposiciones de indemnización habituales.

BrightSpring Health Services (BTSG)는 KKR Phoenix Aggregator L.P.를 포함한 매도주주들에 의한 15,000,000주를 보장하는 2차 공모를 Form S-3ASR에 따라 자동 선반으로 공시했습니다. 공모의 종결 및 관련 주식 재매입은 2025년 10월 22일에 이루어졌습니다.

회사는 본 공모로부터 수익을 받지 못했습니다, 거래와 관련하여 매니지먼트 매도주주들이 주식매수선택권을 행사하여 받은 현금을 제외하고는 그렇습니다. BrightSpring은 공모의 일환으로 1,500,000주를 주간사로부터 재매입했으며, 재매입된 주식에 대해 주간사는 인수수수료를 받지 않았습니다. 인수계약에는 관례적인 진술, 조건 및 면책 조항이 포함됩니다.

BrightSpring Health Services (BTSG) a annoncé une offre secondaire souscrite de 15 000 000 actions ordinaires par des actionnaires vendeurs, y compris KKR Phoenix Aggregator L.P., dans le cadre d’un shelf automatique conformément au formulaire S-3ASR. La clôture de l’offre et le rachat d’actions associé ont eu lieu le 22 octobre 2025.

La Société n’a pas reçu de produits de l’offre, à l’exception des liquidités reçues lors de l’exercice des options sur actions des Actionnaires de gestion vendeurs dans le cadre de la transaction. BrightSpring a racheté 1 500 000 actions auprès du teneur de livre dans le cadre de l’offre, et le teneur de livre n’a pas reçu de frais de souscription sur les actions rachetées. L’accord de souscription comprend des déclarations, des conditions et des dispositions d’indemnisation conformes à la pratique.

BrightSpring Health Services (BTSG) gab eine garantierte Sekundärzeichnung von 15.000.000 Stammaktien durch vendende Aktionäre, darunter KKR Phoenix Aggregator L.P., im Rahmen eines automatischen Shelf gemäß Formular S-3ASR bekannt. Der Abschluss der Emission und der damit verbundene Aktienrückkauf fanden am 22. Oktober 2025 statt.

Das Unternehmen erhielt keine Erlöse aus dem Angebot, außer Bargeld aus der Ausübung von Aktienoptionen der Management Selling Stockholders im Zusammenhang mit der Transaktion. BrightSpring hat 1.500.000 Aktien vom Underwriter als Teil des Angebots zurückerworben, und der Underwriter erhielt für die zurückgekauften Aktien keine Zeichnungsgebühren. Der Unterzeichnungsvereinbarung enthält übliche Zusicherungen, Bedingungen und Freistellungsbestimmungen.

أعلنت BrightSpring Health Services (BTSG) عن عرض ثانوي مكتتب عليه يضم 15,000,000 سهماً من الأسهم العادية من قبل المساهمين البائعين، بما في ذلك KKR Phoenix Aggregator L.P., في إطار مخزون تلقائي وفق Form S-3ASR. أُغلق العرض وإعادة شراء الأسهم المرتبطة في 22 أكتوبر 2025.

لم تتلق الشركة أي عائدات من العرض، باستثناء النقد المستلم من تمارين خيارات أسهم المدراء من قِبل المساهمين المدراء البائعين فيما يتعلق بالصفقة. أعادت BrightSpring شراء 1,500,000 سهم من المكتتب كجزء من العرض، ولم يتلقِ المكتتب أتعاب الاكتتاب عن الأسهم المعادة الشراء. يتضمن اتفاق الاكتتاب التصريحات والظروف والتعويضات المعتادة.

BrightSpring Health Services (BTSG) 通过包括 KKR Phoenix Aggregator L.P. 在内的卖方股东,依据 S-3ASR 自动货架系统披露了 15,000,000 股普通股的承销次发行。该发行的完成及相关回购股份于 2025 年 10 月 22 日完成。

公司未从本次发行中获得收益,仅来自管理层卖方股东在本次交易中行使其股票期权所收到的现金。 BrightSpring 已从承销商处回购 1,500,000 股,作为本次发行的一部分,且承销商未就回购股份获得承销费。承销协议包含惯常的陈述、条件及赔偿条款。

Positive
  • None.
Negative
  • None.

Insights

Secondary sale by sponsors; company executes a concurrent buyback.

The transaction is a secondary offering of 15,000,000 shares sold by existing holders, which means proceeds go to the selling stockholders rather than the company. The company notes cash only from option exercises tied to management participants, indicating no primary capital raise.

BrightSpring also repurchased 1,500,000 shares from the underwriter within the deal. The underwriter waived fees on those repurchased shares, which modestly reduces frictional costs. The agreement is described as customary, with standard indemnities and closing conditions.

The closing occurred on October 22, 2025. Actual market impact hinges on holder supply and the scale of the repurchase relative to float, which isn’t quantified here beyond the 1,500,000-share figure.

BrightSpring Health Services (BTSG) ha annunciato un'offerta secondaria garantita di 15.000.000 azioni ordinarie da parte degli azionisti venditori, tra cui KKR Phoenix Aggregator L.P., nell'ambito di un deposito automatico conforme al Form S-3ASR. Il completamento dell'offerta e il relativo riacquisto di azioni hanno avuto luogo il 22 ottobre 2025.

L'azienda non ha incassato proventi dall'offerta, se non i contanti ricevuti dall'esercizio delle opzioni azionarie da parte degli Management Selling Stockholders in relazione all'operazione. BrightSpring ha riacquistato 1.500.000 azioni dall'intermediario come parte dell'offerta, e l'intermediario non ha ricevuto commissioni di sottoscrizione sulle azioni riacquistate. L'accordo di sottoscrizione comprende dichiarazioni, condizioni e disposizioni di indennizzo di prassi.

BrightSpring Health Services (BTSG) divulgó una oferta secundaria garantizada de 15,000,000 acciones comunes por parte de accionistas vendedores, entre ellos KKR Phoenix Aggregator L.P., dentro de un aumento automático según el Formulario S-3ASR. El cierre de la oferta y la recompra de acciones relacionada se realizó el 22 de octubre de 2025.

La Compañía no recibió ingresos de la oferta, excepto el efectivo recibido por los ejercicios de opciones de acciones de los accionistas de administración vendedores en relación con la transacción. BrightSpring recompró 1,500,000 acciones de la aseguradora como parte de la oferta, y la aseguradora no recibió comisiones de suscripción sobre las acciones recompradas. El acuerdo de suscripción incluye representaciones, condiciones y disposiciones de indemnización habituales.

BrightSpring Health Services (BTSG)는 KKR Phoenix Aggregator L.P.를 포함한 매도주주들에 의한 15,000,000주를 보장하는 2차 공모를 Form S-3ASR에 따라 자동 선반으로 공시했습니다. 공모의 종결 및 관련 주식 재매입은 2025년 10월 22일에 이루어졌습니다.

회사는 본 공모로부터 수익을 받지 못했습니다, 거래와 관련하여 매니지먼트 매도주주들이 주식매수선택권을 행사하여 받은 현금을 제외하고는 그렇습니다. BrightSpring은 공모의 일환으로 1,500,000주를 주간사로부터 재매입했으며, 재매입된 주식에 대해 주간사는 인수수수료를 받지 않았습니다. 인수계약에는 관례적인 진술, 조건 및 면책 조항이 포함됩니다.

BrightSpring Health Services (BTSG) a annoncé une offre secondaire souscrite de 15 000 000 actions ordinaires par des actionnaires vendeurs, y compris KKR Phoenix Aggregator L.P., dans le cadre d’un shelf automatique conformément au formulaire S-3ASR. La clôture de l’offre et le rachat d’actions associé ont eu lieu le 22 octobre 2025.

La Société n’a pas reçu de produits de l’offre, à l’exception des liquidités reçues lors de l’exercice des options sur actions des Actionnaires de gestion vendeurs dans le cadre de la transaction. BrightSpring a racheté 1 500 000 actions auprès du teneur de livre dans le cadre de l’offre, et le teneur de livre n’a pas reçu de frais de souscription sur les actions rachetées. L’accord de souscription comprend des déclarations, des conditions et des dispositions d’indemnisation conformes à la pratique.

BrightSpring Health Services (BTSG) gab eine garantierte Sekundärzeichnung von 15.000.000 Stammaktien durch vendende Aktionäre, darunter KKR Phoenix Aggregator L.P., im Rahmen eines automatischen Shelf gemäß Formular S-3ASR bekannt. Der Abschluss der Emission und der damit verbundene Aktienrückkauf fanden am 22. Oktober 2025 statt.

Das Unternehmen erhielt keine Erlöse aus dem Angebot, außer Bargeld aus der Ausübung von Aktienoptionen der Management Selling Stockholders im Zusammenhang mit der Transaktion. BrightSpring hat 1.500.000 Aktien vom Underwriter als Teil des Angebots zurückerworben, und der Underwriter erhielt für die zurückgekauften Aktien keine Zeichnungsgebühren. Der Unterzeichnungsvereinbarung enthält übliche Zusicherungen, Bedingungen und Freistellungsbestimmungen.

0001865782false0001865782btsg:SixPointSevenFivePercentageTangibleEquityUnitsMember2025-10-202025-10-2000018657822025-10-202025-10-200001865782us-gaap:CommonStockMember2025-10-202025-10-20

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 20, 2025

 

 

BrightSpring Health Services, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-41938

82-2956404

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

805 N. Whittington Parkway

 

Louisville, Kentucky

 

40222

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 502 394-2100

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.01 per share

 

BTSG

 

The Nasdaq Stock Market LLC

6.75% Tangible Equity Units

 

BTSGU

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 1.01 Entry into a Material Definitive Agreement.

On October 20, 2025, BrightSpring Health Services, Inc. (the “Company”) entered into an underwriting agreement with KKR Phoenix Aggregator L.P. (the “KKR Selling Stockholder”), the Management Selling Stockholders (as defined therein) (together with the KKR Selling Stockholder, the “Selling Stockholders”), and BofA Securities, Inc. (the “Underwriter”), relating to an underwritten offering (the “Offering”) of 15,000,000 shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”). The closing of the Offering and the Share Repurchase (as defined below) occurred on October 22, 2025.

Pursuant to the Underwriting Agreement, all 15,000,000 shares of Common Stock were sold by the Selling Stockholders. The Company did not receive any proceeds from the Offering, other than proceeds received in connection with the cash exercise of stock options by the Management Selling Stockholders in connection with the Offering.

The Company purchased 1,500,000 shares of Common Stock from the Underwriter as part of the Offering (the “Share Repurchase”). The Underwriter did not receive any underwriting fees for the shares of Common Stock repurchased by the Company in the Share Repurchase.

The Offering by the Selling Stockholders was made pursuant an automatic shelf registration statement on Form S-3ASR (File No. 333-287916) (the “Registration Statement”), filed on June 10, 2025 with the Securities and Exchange Commission (the “SEC”), a prospectus included in the Registration Statement, and a preliminary prospectus supplement and final prospectus supplement, filed with the SEC on October 20, 2025 and October 21, 2025, respectively.

The Underwriting Agreement contains customary representations, warranties and covenants, customary conditions to closing, indemnification obligations of the Company, the Selling Stockholders and the Underwriter, including for liabilities under the Securities Act of 1933, as amended, and other obligations of the parties. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties.

The foregoing description of the Underwriting Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the full text of the Underwriting Agreement, which is incorporated herein by reference and filed as Exhibit 1.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

Number

 

 

Description

1.1

 

Underwriting Agreement, dated as of October 20, 2025, by and among BrightSpring Health Services, Inc., the Selling Stockholders, and BofA Securities, Inc.

5.1

 

Opinion of Barnes & Thornburg LLP.

23.1

 

Consent of Barnes & Thornburg LLP (included in Exhibit 5.1).

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

BRIGHTSPRING HEALTH SERVICES, INC.

 

 

 

 

Date:

October 22, 2025

By:

/s/ Jennifer Phipps

 

 

Name:

Title:

Jennifer Phipps
Executive Vice President and Chief Financial Officer

 


FAQ

What did BrightSpring Health Services (BTSG) announce in this 8-K?

An underwritten secondary offering of 15,000,000 shares of common stock by selling stockholders, which closed on October 22, 2025.

Did BrightSpring (BTSG) receive proceeds from the offering?

No. The company did not receive proceeds from the offering, other than cash from management stock option exercises connected to the transaction.

Did BrightSpring repurchase shares as part of the transaction?

Yes. BrightSpring repurchased 1,500,000 shares from the underwriter, and the underwriter received no underwriting fees on those shares.

Who were the selling stockholders in the BrightSpring offering?

They included KKR Phoenix Aggregator L.P. and Management Selling Stockholders.

Under what registration was the BrightSpring secondary offering made?

It was made under an automatic shelf registration statement on Form S-3ASR (File No. 333-287916).

When did the BrightSpring offering and repurchase close?

The offering and the share repurchase closed on October 22, 2025.
BrightSpring Health Services, Inc.

NASDAQ:BTSG

BTSG Rankings

BTSG Latest News

BTSG Latest SEC Filings

BTSG Stock Data

5.84B
98.23M
3.22%
113.75%
8.97%
Health Information Services
Services-home Health Care Services
Link
United States
LOUISVILLE